hotspot -WSS

hotspot

author：focus 2025-09-06 03:39:44 - browse：7

Two boxes of Ozempic stack on each other, while one lean on the stack tilted — health coverage from STAT — SEBASTIEN BOZON/AFP via Getty Images

Novo Nordisk’s Ozempic cut the risk of death in a trial of patients with type 2 diabetes and chronic kidney disease, suggesting it may offer some added benefits over other classes of drugs approved to treat this population.

Specifically, the diabetes drug cut the risk of cardiovascular-related deaths by 29% and all-cause deaths by 20%. Given the study parameters, this implies that over three years, 39 people would need to be treated to prevent one death from any cause, according to new results presented Friday at a meeting of the European Renal Association and published in the New England Journal of Medicine.

Ozempic also lowered the risk of major heart complications — including cardiovascular-related death, heart attack, or stroke — by 18%, driven primarily by the reduced rate of heart-linked death.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Achieving telehealth equity for people with hearing loss

knowledge

WSS

Guardant Health colon cancer test endorsed by FDA advisory panel

Recent heat wave in the Mediterranean caused by climate change: Study

Unmasking the 'centricity' illusion in clinical trials

Swim instructor mom warns parents not to buy blue swimsuits for kids

The world needs the new pandemic treaty

Unmasking the 'centricity' illusion in clinical trials

Wikipedia

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

BioMarin wins approval for gene therapy to treat hemophilia A

ACA's risk program benefits Blue Cross Blue Shield insurers

Duchenne breakthrough therapy leaves behind pioneering families

Tulsa Race Massacre survivors and attorneys respond to dismissal of lawsuit

Malaria cases in Florida and Texas: Here’s what you need to know

Tulsa Race Massacre survivors and attorneys respond to dismissal of lawsuit

Moonlake's readout produced a cash windfall. Risks remain

Achieving telehealth equity for people with hearing loss

How to save PrEP access — and even expand it

Judge agrees to delay next hearing in Trump classified documents case

knowledge

Hospitals need to get ahead of regulations on climate change

US sending controversial cluster munitions to Ukraine until other ammo is ready: Kirby

Louisiana bill approved classifying abortion pills as controlled substances

The U.S. needs a new definition of substance use “recovery”

U.S. death rates show how politics are affecting public health

Bird flu makes raw milk dangerous to consume, mouse study finds

knowledge

focus

explore

hotspot